Bangor exploits cell spotter

May 7, 1999

Engineers at University of Wales, Bangor, have joined forces with a new biomedical company in the United States to exploit an electronic method for rapidly detecting cancer cells.

Developed by a team led by Bangor's Ronald Pethig, the technique can distinguish cell types by their response to an electric field. It will be exploited by California-based Aura Diagnostics, which hopes soon to finalise Pounds 3-4 million in backing from venture capitalists. Bangor, as holder of several of the company's patents, is to be a shareholder.

Linda Foster, president and co-founder of Aura Diagnostics, said that the company's Bay Area base allowed it to tap into the region's pool of specialist engineers, biologists, biochemists, managers and investors. Ms Foster said: "We felt the area would be the best location to move the project forward quickly. We believe we will have the technology on the market in about three years."

Please login or register to read this article

Register to continue

Get a month's unlimited access to THE content online. Just register and complete your career summary.

Registration is free and only takes a moment. Once registered you can read a total of 3 articles each month, plus:

  • Sign up for the editor's highlights
  • Receive World University Rankings news first
  • Get job alerts, shortlist jobs and save job searches
  • Participate in reader discussions and post comments

Have your say

Log in or register to post comments